Company
United StatesPublic company, NASDAQ: CAICaris Life Sciences, Inc (NASDAQ: CAI), Phoenix, AZ – FDA Inspections
Inspection records and compliance data for Caris Life Sciences, Inc in Phoenix, Arizona. 2 FDA inspections on record, last inspected September 24, 2024. Publicly traded as NASDAQ: CAI.
Company Profile
This profile covers Caris Life Sciences, Inc based in Phoenix, Arizona, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected June 21, 2024. Last inspected September 24, 2024.
Most cited issue areas
- Environmental control Lack of or inadequate procedures1 inspection
- Process control procedures, Lack of or inadequate procedures1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 24, 2024 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1244053 |
| June 21, 2024 | VAI | Medical Devices & Rad Health · Project Evaluation: Devices | 1241581 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Caris Life Sciences, Inc
Stock ticker
CAI
Exchange
NASDAQ
Share price
$26.12
Market cap
$7.5B
Price as of
November 6, 2026
FEI Number
3008335090
Address
4610 S 44th Pl, Phoenix, Arizona 85040, United States
Country
United States
ID: bc60961d-52f3-4e55-9be9-18c8c7fe49b3